泰林生物收盘上涨1.51%，滚动市盈率258.12倍，总市值27.63亿元

Company Overview - Zhejiang Tailin Biological Technology Co., Ltd. specializes in microbial testing and pollution control, innovative drug research and production, process analysis, and protective measures in the life sciences sector [2] - The company provides high-quality products and solutions for industries such as biomedicine, healthcare, food and beverage, and environmental protection [2] Financial Performance - For Q1 2025, the company reported revenue of 66.94 million yuan, a year-on-year decrease of 16.33% [2] - The net profit for the same period was 3.53 million yuan, down 39.93% year-on-year, with a sales gross margin of 49.27% [2] Market Position - As of July 22, the company's stock closed at 22.8 yuan, with a rolling price-to-earnings (PE) ratio of 258.12, marking a new low in 163 days [1] - The average PE ratio in the medical device industry is 53.47, with a median of 37.00, placing Tailin Biological at the 117th position in the industry ranking [1][3] Shareholding Structure - As of Q1 2025, there is one institutional holder of Tailin Biological, which is a fund holding 511,200 shares valued at 1.1 million yuan [1]